A growing set of downloadable, mix-and-match stem cell resources and activities suitable for a variety of educational settings. All components have been extensively tested, and come with full instructions.
Available in several European languages.
The scale of the medical challenges that an ageing population poses for healthcare in the future will require radical solutions; harnessing the potential of stem cells represents a promising strategy. On 12 November members of the public gathered at King’s College London to discuss issues surrounding stem cell research and how their clinical translation may be realised.
A controversial and unproven stem cell procedure is to be evaluated in a controlled clinical trial, following a vote in the Italian Senate last week.
The Italian Parliament’s Chamber of Deputies had last Monday voted to amend an earlier controversial decree by Italian Senate, which allowed the unproven stem cell method developed by the Stamina Foundation to be used for severely or terminally ill new patients for 18 months.
Earlier this month our partner ECRIN celebrated International Clinical Trials Day with an event in Warsaw.
A specialist discussion event regarding the revision of the EU Clinical Trials Directive (CTD) was held at the European Parliament Information Office in London on the 22nd of February 2013. This event was initiated by EuroStemCell and OptiStem in collaboration with the European Parliament Office in London and featured OptiStem Principal Investigator, Prof Michele De Luca as a panellist. Read on for a description of the event from Georgina Massouraki and a storify summary of lots of interesting event tweets, put together by Corin Campbell.
